Search for: "Dennis Mayo" Results 61 - 80 of 182
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2019, 2:27 pm by Dennis Crouch
by Dennis Crouch Mario and Jose Villena have thus far been stymied in their attempt to obtain patent protection for their claimed “system for distributing real-estate related information. [read post]
27 Feb 2019, 4:14 pm by Dennis Crouch
by Dennis Crouch Hikma Pharmaceuticals USA Inc. v. [read post]
6 Feb 2019, 10:48 am by Dennis Crouch
by Dennis Crouch Athena Diagnostics, Inc. v. [read post]
29 Jan 2019, 11:48 am by Jason Rantanen
It builds on the idea of deferring 101 subject matter until other issues are exhausted first proposed by Robert Merges and Dennis Crouch, but with some important modifications. [read post]
4 Jan 2019, 6:26 pm by Dennis Crouch
Categories of Abstract Ideas: The inquiry of Alice/Mayo Step 1 is whether the patent claim is “directed to” an “abstract idea” or other excluded area. [read post]
3 Dec 2018, 8:46 pm by Dennis Crouch
Lemley, Erik Oliver, Kent Richardson, James Yoon, & Michael Costa, Patent Purchases and Litigation Outcomes, 2016 Patently-O Patent Law Journal 15 (Lemley.2016.PatentMarket) Bernard Chao and Amy Mapes, An Early Look at Mayo’s Impact on Personalized Medicine, 2016 Patently-O Patent Law Journal 10 (Chao.2016.PersonalizedMedicine) James E. [read post]
21 Oct 2018, 2:43 pm by Dennis Crouch
  The article documents “a spike in 101 rejections among select medical diagnostics and software/business method applications following the Alice and Mayo decisions. [read post]
2 Oct 2018, 3:25 am by Dennis Crouch
by Dennis Crouch I wrote earlier about a Natural Alternatives decision regarding priority. [read post]
31 Aug 2018, 9:10 am by Dennis Crouch
by Dennis Crouch A new petition for writ of certiorari focuses attention again on patent eligibility and the law-fact interplay. [read post]
1 Jun 2018, 8:28 am by Dennis Crouch
by Dennis Crouch As part of the court’s en banc denial in Berkheimer v. [read post]
29 Apr 2018, 6:41 pm by Dennis Crouch
by Dennis Crouch 01 Communique Lab. v. [read post]
22 Apr 2018, 6:57 pm by Dennis Crouch
by Dennis Crouch Director Iancu has made clear that the current state of patent eligibility jurisprudence is untenable. [read post]
15 Apr 2018, 6:00 pm by Dennis Crouch
by Dennis Crouch Vanda is an important patent eligibility case drawing a fine line between the the eligible personalized medicine treatment claims and the ineligible methods of Mayo and Ariosa. [read post]
20 Feb 2018, 2:04 am by Dennis Crouch
by Dennis Crouch Ex Parte Simons, APPEAL 2016-002684 (Patent Tr. [read post]